Lv21
116 积分 2025-05-26 加入
Cemiplimab-Induced Cytokine-Release Syndrome: Second Case Reported and Review of The Literature
4小时前
已完结
Cemiplimab-Induced Cytokine-Release Syndrome: Second Case Reported and Review of The Literature
4小时前
已关闭
Cemiplimab-Induced Cytokine-Release Syndrome: Second Case Reported and Review of The Literature
4小时前
已关闭
Cemiplimab-induced cytokine-release syndrome: second case reported and review of the literature
4小时前
已关闭
Analysis of the relationship between histamine H1 receptor antagonists and broad dementia events using the FAERS, JADER, and CVAR databases
8天前
已完结
Postmarketing safety analysis of remimazolam
8天前
已关闭
Immune-related interstitial lung disease induced by different immune checkpoint inhibitors regimens: A real-world study from 2014 to 2022 based on FAERS databases
19天前
已完结
Dermatological Adverse Events Associated with Immune Checkpoint Inhibitor-Based Combinations of Anticancer Therapies: A Systematic Review
27天前
已完结
Sicca syndrome/Sjögren’s disease associated with cancer immunotherapy: a narrative review on clinical presentation, biomarkers, and management
29天前
已完结
Safety and Efficacy of Induction and Maintenance Avelumab Plus R-CHOP in Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Analysis of the Phase II Avr-CHOP Study
29天前
已完结
皖公网安备34019202002308
